Standard BioTools Inc（LAB）價格預測LABStandard BioTools Inc

Alphio's LAB stock price prediction model matches the current Standard BioTools Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.64 (+0.34%). The 1-week path is $0.65 (+1.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Standard BioTools Inc (LAB) is currently trading at $0.6419, which is significantly lower than its 200-day simple moving average of $1.075, indicating a bearish trend. The stock has a low RSI of 24.478, suggesting it is oversold, but this could also indicate continued weakness. Additionally, the forward P/E ratio is 0, reflecting uncertainty in future earnings. While the recent merger with Treeline Biosciences could strengthen its financial position, the company has reported a net income loss of $26,758,000 in Q2 2026, which raises concerns about its profitability and operational efficiency. Given these factors, it may be prudent to hold off on buying until there is clearer evidence of recovery or improvement in financial metrics.

Standard BioTools Inc (LAB) last closed at $0.6419, losing -1.70%. These facts feed the 1-day and 1-week LAB price prediction above.